Sobi to acquire Arthrosi Therapeutics, strengthening pipeline for the potential treatment of gout [Yahoo! Finance]
SVENSKA HANDELSBK UNS/ADR (SVNLY)
NASDAQ:AMEX Investor Relations:
danskebank.com/investor-relations
Company Research
Source: Yahoo! Finance
STOCKHOLM Dec. 13, 2025 /PRNewswire/ -- Sobi® (STO: SOBI) has entered into a definitive agreement to acquire Arthrosi Therapeutics, Inc. (Arthrosi), a private late-stage biotechnology company focused on developing a next-generation treatment for gout. The acquisition strengthens Sobi's gout franchise by adding pozdeutinurad (AR882), an investigational next-generation, once-daily oral URAT1 inhibitor currently being evaluated in two fully recruited global Phase 3 clinical studies for the potential management of progressive and tophaceous gout and expected to read out in 2026. Pozdeutinurad complements Sobi's pipeline by adding a potentially best-in-class URAT1 inhibitor for patients sub-optimally treated with first-line therapies. Today's announcement reflects Sobi's commitment to advancing treatment options for people living with gout. "The acquisition of Arthrosi allows us to expand our gout pipeline with a highly differentiated new asset", said Guido Oelkers, President and CEO of
Show less
Read more
Impact Snapshot
Event Time:
SVNLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SVNLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SVNLY alerts
High impacting SVENSKA HANDELSBK UNS/ADR news events
Weekly update
A roundup of the hottest topics
SVNLY
News
- How Analysts See the Story Changing for Svenska Handelsbanken After Recent Developments [Yahoo! Finance]Yahoo! Finance
- HLPartnership expands lender panel with Handelsbanken addition [Yahoo! Finance]Yahoo! Finance
- Svenska Handelsbanken Ab Publ (OTCMKTS:SVNLY) had its "neutral" rating reaffirmed by analysts at Citigroup Inc..MarketBeat
- Svenska Handelsbanken: A Rock-Solid Bank Trapped In An Overpriced Market [Seeking Alpha]Seeking Alpha
- Why the wheels are coming off the student rental sector [Yahoo! Finance]Yahoo! Finance